Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis

BACKGROUND: Cancer therapy has evolved from non-specific cytotoxic agents to a selective, mechanism-based approach that includes targeted agents and immunotherapy. Although the response to targeted therapies for unresectable hepatocellular carcinoma (HCC) is acceptable with the improved survival, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Teng-Kai, Yu, Ya-Fang, Tsai, Chiao-Ling, Li, Hsing-Ju, Yang, Po-Sheng, Huang, Kai-Wen, Cheng, Jason Chia-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587661/
https://www.ncbi.nlm.nih.gov/pubmed/36271374
http://dx.doi.org/10.1186/s12885-022-10174-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587661/
https://www.ncbi.nlm.nih.gov/pubmed/36271374
http://dx.doi.org/10.1186/s12885-022-10174-6

Ejemplares similares